View in EDS HTML Full Text PDF Full Text

Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation.

Saved in:

Bibliographic Details
Title:	Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation.
Authors:	Li, Duo¹ (AUTHOR), Zhong, Qi¹ (AUTHOR), Xiao, Di¹ (AUTHOR), Wang, Weifan¹ (AUTHOR), Xie, Lejing¹ (AUTHOR), Peng, Mei¹ (AUTHOR), Xu, Cangcang¹ (AUTHOR), Wu, Huaying¹ (AUTHOR), Li, Zhuan¹ (AUTHOR) zhuanli@hunnu.edu.cn, Yang, Xiaoping¹ (AUTHOR) xiaoping.yang@hunnu.edu.cn
Source:	Cancer Cell International. 10/17/2025, Vol. 25 Issue 1, p1-18. 18p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	14752867
DOI:	10.1186/s12935-025-04012-5